Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Jules L. Derks, Robert Jan van Suylen, Erik Thunnissen, Michael A. den Bakker, Harry J. Groen, Egbert F. Smit, Ronald A. Damhuis, Esther C. van den Broek, Ernst-Jan M. Speel, Anne-Marie C. Dingemans*,

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original languageEnglish
Article number1601838
Number of pages9
JournalEuropean Respiratory Journal
Volume49
Issue number6
DOIs
Publication statusPublished - Jun 2017

Keywords

  • MULTICENTER-PHASE-II
  • LUNG-CANCER
  • CLINICAL-PRACTICE
  • CISPLATIN
  • TUMORS
  • CARBOPLATIN
  • IRINOTECAN
  • DIAGNOSIS
  • FEATURES
  • OUTCOMES

Cite this

Derks, Jules L. ; van Suylen, Robert Jan ; Thunnissen, Erik ; den Bakker, Michael A. ; Groen, Harry J. ; Smit, Egbert F. ; Damhuis, Ronald A. ; van den Broek, Esther C. ; Speel, Ernst-Jan M. ; Dingemans, Anne-Marie C. / Chemotherapy for pulmonary large cell neuroendocrine carcinomas : does the regimen matter?. In: European Respiratory Journal. 2017 ; Vol. 49, No. 6.
@article{6b887e10f08b4ebab1ce694a6c3f69b5,
title = "Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?",
keywords = "MULTICENTER-PHASE-II, LUNG-CANCER, CLINICAL-PRACTICE, CISPLATIN, TUMORS, CARBOPLATIN, IRINOTECAN, DIAGNOSIS, FEATURES, OUTCOMES",
author = "Derks, {Jules L.} and {van Suylen}, {Robert Jan} and Erik Thunnissen and {den Bakker}, {Michael A.} and Groen, {Harry J.} and Smit, {Egbert F.} and Damhuis, {Ronald A.} and {van den Broek}, {Esther C.} and Speel, {Ernst-Jan M.} and Dingemans, {Anne-Marie C.}",
year = "2017",
month = "6",
doi = "10.1183/13993003.01838-2016",
language = "English",
volume = "49",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

Derks, JL, van Suylen, RJ, Thunnissen, E, den Bakker, MA, Groen, HJ, Smit, EF, Damhuis, RA, van den Broek, EC, Speel, E-JM, Dingemans, A-MC 2017, 'Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?', European Respiratory Journal, vol. 49, no. 6, 1601838. https://doi.org/10.1183/13993003.01838-2016

Chemotherapy for pulmonary large cell neuroendocrine carcinomas : does the regimen matter? / Derks, Jules L.; van Suylen, Robert Jan; Thunnissen, Erik; den Bakker, Michael A.; Groen, Harry J.; Smit, Egbert F.; Damhuis, Ronald A.; van den Broek, Esther C.; Speel, Ernst-Jan M.; Dingemans, Anne-Marie C.

In: European Respiratory Journal, Vol. 49, No. 6, 1601838, 06.2017.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Chemotherapy for pulmonary large cell neuroendocrine carcinomas

T2 - does the regimen matter?

AU - Derks, Jules L.

AU - van Suylen, Robert Jan

AU - Thunnissen, Erik

AU - den Bakker, Michael A.

AU - Groen, Harry J.

AU - Smit, Egbert F.

AU - Damhuis, Ronald A.

AU - van den Broek, Esther C.

AU - Speel, Ernst-Jan M.

AU - Dingemans, Anne-Marie C.

PY - 2017/6

Y1 - 2017/6

KW - MULTICENTER-PHASE-II

KW - LUNG-CANCER

KW - CLINICAL-PRACTICE

KW - CISPLATIN

KW - TUMORS

KW - CARBOPLATIN

KW - IRINOTECAN

KW - DIAGNOSIS

KW - FEATURES

KW - OUTCOMES

U2 - 10.1183/13993003.01838-2016

DO - 10.1183/13993003.01838-2016

M3 - Article

VL - 49

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 6

M1 - 1601838

ER -

Derks JL, van Suylen RJ, Thunnissen E, den Bakker MA, Groen HJ, Smit EF et al. Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? European Respiratory Journal. 2017 Jun;49(6). 1601838. https://doi.org/10.1183/13993003.01838-2016

Access to Document